secwatch.observer — SEC 8-K summary
======================================

Issuer:     Orthofix Medical Inc. (OFIX)
CIK:        0000884624
Form:       8-K
Filed at:   2021-12-14T23:59:59+00:00
Accession:  0001564590-21-060217
Event type: leadership
Sentiment:  positive
Materiality: 0.40
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Orthofix appoints Thomas A. West to Board; adds medical device expertise
------------------------------------------------------------------------

- Thomas A. West appointed to Orthofix Board effective Dec 13, 2021; Board size increased to nine.
- West is President, CEO & Director of Intersect ENT (XENT), which agreed to be acquired by Medtronic for $1.1B.
- He has 30+ years in med dev including 23 years at Johnson & Johnson and roles at Hologic.
- West will serve on Compensation and Talent Development Committee; granted options for 29,450 shares vesting over 4 years.
- Standard independent director compensation; no related-party transactions disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/884624/000156459021060217/0001564590-21-060217-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/884624/000156459021060217/ofix-8k_20211213.htm
  HTML page:      https://secwatch.observer/filing/0001564590-21-060217

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer